Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-25-000374
Filing Date
2025-11-14
Accepted
2025-11-14 17:00:22
Documents
1
Period of Report
2025-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 11-12-2025 form_4.html 4  
1 FORM 4 FOR 11-12-2025 form_4.xml 4 3543
  Complete submission text file 0001161697-25-000374.txt   5221
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 355 ALHAMBRA CIRCLE CORAL GABLES FL 33134
Business Address
Elsbernd Brian (Reporting) CIK: 0001763511 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 251487899